Mediclinic Southern Africa (Pty) Ltd v Mediclinic Limpopo Ltd (018374) [2014] ZACT 5; [2014] 1 CPLR 109 (CT) (15 April 2014)

Mediclinic Southern Africa (Pty) Ltd v Mediclinic Limpopo Ltd (018374) [2014] ZACT 5; [2014] 1 CPLR 109 (CT) (15 April 2014)

The Tribunal found that the acquisition of an additional 1% shareholding by Mediclinic Southern Africa (Pty) Ltd in Mediclinic Limpopo Ltd would result in de jure sole control, but would not alter the competitive dynamics of the market for private hospital services. Mediclinic already manages and negotiates tariffs...

Source-derived case information.

Citation
[2014] ZACT 5
Parties
Applicant: Mediclinic Southern Africa (Pty) Ltd; Respondent: Mediclinic Limpopo Ltd
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
15 April 2014
Case Number
018374
Procedural Posture
Merger Application / Approval
Outcome
The merger is approved unconditionally.
Judges
T Madima, I Valodia, A Roskam
Legal Topics
Merger Control, Sole Control Acquisition, Tariff Negotiation, Countervailing Power
Competition Law Commercial and Corporate Merger Control Sole Control Acquisition Tariff Negotiation Countervailing Power

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Authorities cited 2 Party arguments 2 Amounts and remedies 2
Sign in to unlock

Parties

Mediclinic Southern Africa (Pty) Ltd

Applicant

Mediclinic Limpopo Ltd

Respondent

Procedural Posture

Merger Application / Approval

Legal Issues

  1. 1 Whether the acquisition of an additional 1% shareholding by Mediclinic Southern Africa (Pty) Ltd in Mediclinic Limpopo Ltd will substantially prevent or lessen competition in the market for private hospital services.
  2. 2 Whether the transaction raises any public interest concerns under the Competition Act.

Ratio Decidendi

The Tribunal found that the acquisition of an additional 1% shareholding by Mediclinic Southern Africa (Pty) Ltd in Mediclinic Limpopo Ltd would result in de jure sole control, but would not alter the competitive dynamics of the market for private hospital services. Mediclinic already manages and negotiates tariffs for Limpopo Hospital, and the transaction does not change market shares or create horizontal or vertical overlaps. The presence of strong countervailing power through administrators and collective bargaining by medical schemes further mitigates any potential anti-competitive effects. No public interest issues were identified. Accordingly, the Tribunal concluded that the...

Court Disposition

The merger is approved unconditionally.

Orders

  • The acquisition by Mediclinic Southern Africa (Pty) Ltd of an additional 1% shareholding in Mediclinic Limpopo Ltd is approved without conditions.